FDA Approves Seventh Ustekinumab Biosimilar, Steqeyma ...Middle East

News by : (Medscape) -
Ustekinumab-stba, manufactured by Celltrion, is expected to be marketed in the United States in February 2025. Medscape Medical News

Hence then, the article about fda approves seventh ustekinumab biosimilar steqeyma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Seventh Ustekinumab Biosimilar, Steqeyma )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار